Wunderlich Hikes Intrexon To $70, Sees 'Software/Biotech Hybrid' As A Key Strength
July 27, 2015 at 09:18 AM EDT
In a report published Monday, Wunderlich analyst Rob Breza maintained a Buy rating on Intrexon Corp(NYSE: XON), while raising ...
